Sang Nguyen1, Honglan Li2, Danxia Yu1, Jing Gao2, Yutang Gao2, Huong Tran3,4, Yong-Bing Xiang2, Wei Zheng1, Xiao-Ou Shu1. 1. Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. 2. Department of Epidemiology, China State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. 3. Vietnam National Cancer Institute, Hanoi, Vietnam. 4. Department of Medical Ethics and Psychology, Hanoi Medical University, Hanoi, Vietnam.
Abstract
BACKGROUND: Understanding the association between diet and colorectal cancer (CRC) risk is essential to curbing the epidemic of this cancer. This study prospectively evaluated adherence to the Chinese Food Pagoda (CHFP), and two American Dietary Guidelines: the Alternative Healthy Eating Index (AHEI-2010) and the Dietary Approaches to Stop Hypertension (DASH) in association with CRC risk among Chinese adults living in urban Shanghai, China. METHODS: Participants included 60 161 men and 72 445 women aged 40-74, from two ongoing population-based prospective cohort studies. Associations between dietary guideline compliance scores and CRC risk were evaluated by Cox proportional hazard regression analyses, with age as time metric, and potential confounders were adjusted. RESULTS: We identified 1670 CRC incidence cases (691 males and 979 females) during an average 8.1 years of follow-up for men and 13.4 years for women. CHFP score was inversely associated with risk of CRC, with hazard ratios (HRs) (95% confidence intervals) of 0.88 (0.77, 1.00), 0.86 (0.75, 0.98) and 0.84 (0.73, 0.96) for the 2nd, 3rd and 4th quartiles versus 1st quartile, respectively (Ptrend= 0.01). The inverse association appeared stronger for rectal cancer, individuals at younger age (< 50 years), with a lower BMI (<25 kg/m2) or without any metabolic conditions at baseline, although no multiplicative interactions were noted. No consistent association pattern was observed for the modified DASH score and the modified AHEI-2010. CONCLUSIONS: Compliance with the Dietary Guidelines for Chinese was associated with reduced risk of CRC among Chinese adults. To maximize health impacts, dietary recommendations need to be tailored for specific populations.
BACKGROUND: Understanding the association between diet and colorectal cancer (CRC) risk is essential to curbing the epidemic of this cancer. This study prospectively evaluated adherence to the Chinese Food Pagoda (CHFP), and two American Dietary Guidelines: the Alternative Healthy Eating Index (AHEI-2010) and the Dietary Approaches to Stop Hypertension (DASH) in association with CRC risk among Chinese adults living in urban Shanghai, China. METHODS: Participants included 60 161 men and 72 445 women aged 40-74, from two ongoing population-based prospective cohort studies. Associations between dietary guideline compliance scores and CRC risk were evaluated by Cox proportional hazard regression analyses, with age as time metric, and potential confounders were adjusted. RESULTS: We identified 1670 CRC incidence cases (691 males and 979 females) during an average 8.1 years of follow-up for men and 13.4 years for women. CHFP score was inversely associated with risk of CRC, with hazard ratios (HRs) (95% confidence intervals) of 0.88 (0.77, 1.00), 0.86 (0.75, 0.98) and 0.84 (0.73, 0.96) for the 2nd, 3rd and 4th quartiles versus 1st quartile, respectively (Ptrend= 0.01). The inverse association appeared stronger for rectal cancer, individuals at younger age (< 50 years), with a lower BMI (<25 kg/m2) or without any metabolic conditions at baseline, although no multiplicative interactions were noted. No consistent association pattern was observed for the modified DASH score and the modified AHEI-2010. CONCLUSIONS: Compliance with the Dietary Guidelines for Chinese was associated with reduced risk of CRC among Chinese adults. To maximize health impacts, dietary recommendations need to be tailored for specific populations.
Authors: Marjorie L McCullough; Diane Feskanich; Meir J Stampfer; Edward L Giovannucci; Eric B Rimm; Frank B Hu; Donna Spiegelman; David J Hunter; Graham A Colditz; Walter C Willett Journal: Am J Clin Nutr Date: 2002-12 Impact factor: 7.045
Authors: Anita Koushik; David J Hunter; Donna Spiegelman; W Lawrence Beeson; Piet A van den Brandt; Julie E Buring; Eugenia E Calle; Eunyoung Cho; Gary E Fraser; Jo L Freudenheim; Charles S Fuchs; Edward L Giovannucci; R Alexandra Goldbohm; Lisa Harnack; David R Jacobs; Ikuko Kato; Vittorio Krogh; Susanna C Larsson; Michael F Leitzmann; James R Marshall; Marjorie L McCullough; Anthony B Miller; Pirjo Pietinen; Thomas E Rohan; Arthur Schatzkin; Sabina Sieri; Mikko J Virtanen; Alicja Wolk; Anne Zeleniuch-Jacquotte; Shumin M Zhang; Stephanie A Smith-Warner Journal: J Natl Cancer Inst Date: 2007-09-25 Impact factor: 13.506
Authors: Annie On On Chan; Man Hong Jim; Kwok Fai Lam; Jeffrey S Morris; David Chun Wah Siu; Teresa Tong; Fook Hong Ng; Siu Yin Wong; Wai Mo Hui; Chi Kuen Chan; Kam Chuen Lai; Ting Kin Cheung; Pierre Chan; Grace Wong; Man Fung Yuen; Yuk Kong Lau; Stephen Lee; Ming Leung Szeto; Benjamin C Y Wong; Shiu Kum Lam Journal: JAMA Date: 2007-09-26 Impact factor: 56.272
Authors: J Reedy; P N Mitrou; S M Krebs-Smith; E Wirfält; A Flood; V Kipnis; M Leitzmann; T Mouw; A Hollenbeck; A Schatzkin; A F Subar Journal: Am J Epidemiol Date: 2008-06-04 Impact factor: 4.897
Authors: Ashley J Vargas; Marian L Neuhouser; Stephanie M George; Cynthia A Thomson; Gloria Y F Ho; Thomas E Rohan; Ikuko Kato; Rami Nassir; Lifang Hou; JoAnn E Manson Journal: Am J Epidemiol Date: 2016-06-05 Impact factor: 4.897
Authors: L J Appel; T J Moore; E Obarzanek; W M Vollmer; L P Svetkey; F M Sacks; G A Bray; T M Vogt; J A Cutler; M M Windhauser; P H Lin; N Karanja Journal: N Engl J Med Date: 1997-04-17 Impact factor: 91.245
Authors: Mona Hashim; Dana N Abdelrahim; Shatha Ahmed; Besma Tahir; Mariam Youssef; Joud Mousannef; Moza Almazrouei; Farah Naja; Nabeel Al-Yateem; Syed Azizur Rahman; Moez Al Islam E Faris Journal: Asian Pac J Cancer Prev Date: 2022-03-01